Analyze Diet
Journal of veterinary internal medicine2008; 22(4); 826-831; doi: 10.1111/j.1939-1676.2008.0117.x

Electrochemotherapy in veterinary oncology.

Abstract: Electropermeabilization is a method that uses electric field pulses to induce an electrically mediated reorganization of the plasma membrane of cells. Electrochemotherapy combines local or systemic administration of chemotherapeutic drugs such as bleomycin or cisplatin that have poor membrane permeability with electropermeabilization by direct application of electric pulses to the tumors. Preclinical studies have demonstrated excellent antitumor effectiveness of electrochemotherapy on different animal models and various tumor types, minimal toxicity, and safety of the procedure. Based on results of preclinical studies, clinical studies were conducted in human patients, which demonstrated pronounced antitumor effectiveness of electrochemotherapy with 80-85% objective responses of the treated cutaneous and SC tumors. Clinical studies in veterinary oncology have demonstrated that electrochemotherapy is very effective in the treatment of cutaneous and SC tumors of different histologic types in cats, dogs, and horses. The results of these studies have also demonstrated approximately 80% long-lasting objective responses of tumors treated by electrochemotherapy. Primary tumors of different histologic types were treated. Electrochemotherapy in veterinary oncology has future promise to be highly effective, and could be used to treat primary or recurrent solitary or multiple cutaneous and SC tumors of different histology or as an adjuvant treatment to surgery.
Publication Date: 2008-06-10 PubMed ID: 18537879DOI: 10.1111/j.1939-1676.2008.0117.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article presents a study on the effectiveness of electrochemotherapy, a method that combines chemotherapy with electricity, for the treatment of tumors in animals. The study found that electrochemotherapy, when used to treat various tumor types in cats, dogs, and horses, showed promising results, with around 80% long-lasting responses and minimal toxicity, indicating that it could potentially be a highly effective treatment method in veterinary oncology.

Understanding Electrochemotherapy

  • Electrochemotherapy is a treatment method that combines the use of chemotherapeutic drugs with electropermeabilization, a procedure that involves the use of electric fields to rearrange the cells’ plasma membrane. This facilitates the entry of the chemotherapeutic drugs, which normally have poor membrane permeability, into the cells.
  • This technique is particularly used with drugs such as bleomycin or cisplatin, which are typically used in chemotherapy. The electric pulses are directly applied to the tumors.

Preclinical and Clinical Studies

  • The article highlights that preclinical studies on different animal models have shown that electrochemotherapy is extremely effective against various types of tumors, demonstrating minimal toxicity and safety of the procedure.
  • In addition to the preclinical studies, clinical studies were also conducted on human patients, which further corroborated the high efficacy of electrochemotherapy. Around 80-85% objective responses were observed in the treated cutaneous and subcutaneous (SC) tumors.

Electrochemotherapy in Veterinary Oncology

  • The research extends its focus to veterinary oncology, underlining that electrochemotherapy proves very effective in treating different histologic types of cutaneous and SC tumors in cats, dogs, and horses.
  • Similar to the results in human patients, around 80% long-lasting objective responses were observed in the animal tumors treated with electrochemotherapy.
  • The technique was used to treat primary tumors of different histologic types.

Future Implications

  • The study supports the promising potential of electrochemotherapy in veterinary oncology as it has shown to be highly effective in the treatment of various tumor types.
  • It suggests that the technique could be used to treat both primary or recurrent solitary or multiple cutaneous and subcutaneous tumors of different histology.
  • Moreover, electrochemotherapy could also serve as an adjuvant treatment to surgery, increasing the chances of successful tumor removal and recovery.

Cite This Article

APA
Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J. (2008). Electrochemotherapy in veterinary oncology. J Vet Intern Med, 22(4), 826-831. https://doi.org/10.1111/j.1939-1676.2008.0117.x

Publication

ISSN: 0891-6640
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 22
Issue: 4
Pages: 826-831

Researcher Affiliations

Cemazar, M
  • Institute of Oncology Ljubljana, University of Ljubljana, Ljubljana, Slovenia the Ecole Vétérinaire de Toulouse, Toulouse, France.
Tamzali, Y
    Sersa, G
      Tozon, N
        Mir, L M
          Miklavcic, D
            Lowe, R
              Teissie, J

                MeSH Terms

                • Animal Diseases / therapy
                • Animals
                • Electrochemotherapy / instrumentation
                • Electrochemotherapy / methods
                • Electrochemotherapy / veterinary
                • Humans
                • Neoplasms / therapy
                • Neoplasms / veterinary

                Citations

                This article has been cited 27 times.
                1. Tellado M, Michinski S, Impellizeri J, Marshall G, Signori E, Maglietti F. Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma - a translational model.. Cancer Drug Resist 2022;5(3):595-611.
                  doi: 10.20517/cdr.2022.24pubmed: 36176753google scholar: lookup
                2. Tellado M, Mir LM, Maglietti F. Veterinary Guidelines for Electrochemotherapy of Superficial Tumors.. Front Vet Sci 2022;9:868989.
                  doi: 10.3389/fvets.2022.868989pubmed: 35968026google scholar: lookup
                3. Fonseca-Alves CE, Ferreira Ê, de Oliveira Massoco C, Strauss BE, Fávaro WJ, Durán N, Oyafuso da Cruz N, Dos Santos Cunha SC, Castro JLC, Rangel MMM, Brunner CHM, Tellado M, Dos Anjos DS, Fernandes SC, Barbosa de Nardi A, Biondi LR, Dagli MLZ. Current Status of Canine Melanoma Diagnosis and Therapy: Report From a Colloquium on Canine Melanoma Organized by ABROVET (Brazilian Association of Veterinary Oncology).. Front Vet Sci 2021;8:707025.
                  doi: 10.3389/fvets.2021.707025pubmed: 34485435google scholar: lookup
                4. Brloznik M, Boc N, Cemazar M, Sersa G, Bosnjak M, Brezar SK, Pavlin D. Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma.. Sci Rep 2021 Jun 29;11(1):13446.
                  doi: 10.1038/s41598-021-92820-wpubmed: 34188103google scholar: lookup
                5. Brloznik M, Kranjc Brezar S, Boc N, Knific T, Cemazar M, Milevoj N, Sersa G, Tozon N, Pavlin D. Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer.. Front Vet Sci 2021;8:679073.
                  doi: 10.3389/fvets.2021.679073pubmed: 34095282google scholar: lookup
                6. Maglietti F, Tellado M, De Robertis M, Michinski S, Fernández J, Signori E, Marshall G. Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America.. Vaccines (Basel) 2020 Sep 17;8(3).
                  doi: 10.3390/vaccines8030537pubmed: 32957424google scholar: lookup
                7. Chung TH, Stancampiano A, Sklias K, Gazeli K, André FM, Dozias S, Douat C, Pouvesle JM, Santos Sousa J, Robert É, Mir LM. Cell Electropermeabilisation Enhancement by Non-Thermal-Plasma-Treated PBS.. Cancers (Basel) 2020 Jan 16;12(1).
                  doi: 10.3390/cancers12010219pubmed: 31963132google scholar: lookup
                8. Byron CR, DeWitt MR, Latouche EL, Davalos RV, Robertson JL. Treatment of Infiltrative Superficial Tumors in Awake Standing Horses Using Novel High-Frequency Pulsed Electrical Fields.. Front Vet Sci 2019;6:265.
                  doi: 10.3389/fvets.2019.00265pubmed: 31475163google scholar: lookup
                9. Garabalino MA, Olaiz N, Portu A, Saint Martin G, Thorp SI, Pozzi ECC, Curotto P, Itoiz ME, Monti Hughes A, Colombo LL, Nigg DW, Trivillin VA, Marshall G, Schwint AE. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.. Radiat Environ Biophys 2019 Aug;58(3):455-467.
                  doi: 10.1007/s00411-019-00796-zpubmed: 31123853google scholar: lookup
                10. Racnik J, Svara T, Zadravec M, Gombac M, Cemazar M, Sersa G, Tozon N. Electrochemotherapy with Bleomycin of Different types of Cutaneous Tumours in a Ferret (Mustela Putorius Furo).. Radiol Oncol 2018 Mar;52(1):98-104.
                  doi: 10.1515/raon-2017-0057pubmed: 29520211google scholar: lookup
                11. Maglietti F, Tellado M, Olaiz N, Michinski S, Marshall G. Minimally Invasive Electrochemotherapy Procedure for Treating Nasal Duct Tumors in Dogs using a Single Needle Electrode.. Radiol Oncol 2017 Dec;51(4):422-430.
                  doi: 10.1515/raon-2017-0043pubmed: 29333121google scholar: lookup
                12. Zhao D, Wu M, Huang D, Liang Z, Wei Z, Li Z. Parametric optimization of electric field strength for cancer electrochemotherapy on a chip-based model.. Theranostics 2018;8(2):358-368.
                  doi: 10.7150/thno.21099pubmed: 29290813google scholar: lookup
                13. Kranjc S, Cemazar M, Sersa G, Scancar J, Grabner S. In Vitro and in vivo Evaluation of Electrochemotherapy with trans-platinum Analogue trans-[PtCl(2)(3-Hmpy)(2)].. Radiol Oncol 2017 Sep;51(3):295-306.
                  doi: 10.1515/raon-2017-0034pubmed: 28959166google scholar: lookup
                14. Salvadori C, Svara T, Rocchigiani G, Millanta F, Pavlin D, Cemazar M, Lampreht Tratar U, Sersa G, Tozon N, Poli A. Effects of Electrochemotherapy with Cisplatin and Peritumoral IL-12 Gene Electrotransfer on Canine Mast Cell Tumors: a Histopathologic and Immunohistochemical Study.. Radiol Oncol 2017 Sep;51(3):286-294.
                  doi: 10.1515/raon-2017-0035pubmed: 28959165google scholar: lookup
                15. Tozon N, Lampreht Tratar U, Znidar K, Sersa G, Teissie J, Cemazar M. Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats.. J Vis Exp 2016 Oct 24;(116).
                  doi: 10.3791/54760pubmed: 27805594google scholar: lookup
                16. Maglietti F, Tellado M, Olaiz N, Michinski S, Marshall G. Combined local and systemic bleomycin administration in electrochemotherapy to reduce the number of treatment sessions.. Radiol Oncol 2016 Mar 1;50(1):58-63.
                  doi: 10.1515/raon-2016-0015pubmed: 27069450google scholar: lookup
                17. Kranjc S, Kranjc M, Scancar J, Jelenc J, Sersa G, Miklavcic D. Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo.. Radiol Oncol 2016 Mar 1;50(1):39-48.
                  doi: 10.1515/raon-2016-0014pubmed: 27069448google scholar: lookup
                18. Marčan M, Pavliha D, Kos B, Forjanič T, Miklavčič D. Web-based tool for visualization of electric field distribution in deep-seated body structures and planning of electroporation-based treatments.. Biomed Eng Online 2015;14 Suppl 3(Suppl 3):S4.
                  doi: 10.1186/1475-925X-14-S3-S4pubmed: 26356007google scholar: lookup
                19. Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.. Radiol Oncol 2015 Jun;49(2):147-54.
                  doi: 10.1515/raon-2015-0013pubmed: 26029026google scholar: lookup
                20. Venslauskas MS, Šatkauskas S. Mechanisms of transfer of bioactive molecules through the cell membrane by electroporation.. Eur Biophys J 2015 Jul;44(5):277-89.
                  doi: 10.1007/s00249-015-1025-xpubmed: 25939984google scholar: lookup
                21. Bosnjak M, Lorente BC, Pogacar Z, Makovsek V, Cemazar M. Different incubation times of cells after gene electrotransfer in fetal bovine serum affect cell viability, but not transfection efficiency.. J Membr Biol 2014 May;247(5):421-8.
                  doi: 10.1007/s00232-014-9649-9pubmed: 24648010google scholar: lookup
                22. Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice.. Biomed Eng Online 2014 Mar 12;13(1):29.
                  doi: 10.1186/1475-925X-13-29pubmed: 24621079google scholar: lookup
                23. Fini M, Salamanna F, Parrilli A, Martini L, Cadossi M, Maglio M, Borsari V. Electrochemotherapy is effective in the treatment of rat bone metastases.. Clin Exp Metastasis 2013 Dec;30(8):1033-45.
                  doi: 10.1007/s10585-013-9601-xpubmed: 23832763google scholar: lookup
                24. Corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D. Modeling of electric field distribution in tissues during electroporation.. Biomed Eng Online 2013 Feb 21;12:16.
                  doi: 10.1186/1475-925X-12-16pubmed: 23433433google scholar: lookup
                25. Pavlin D, Cemazar M, Cör A, Sersa G, Pogacnik A, Tozon N. Electrogene therapy with interleukin-12 in canine mast cell tumors.. Radiol Oncol 2011 Mar;45(1):31-9.
                  doi: 10.2478/v10019-010-0041-9pubmed: 22933932google scholar: lookup
                26. Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li S. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.. Cancer Gene Ther 2010 Jul;17(7):457-64.
                  doi: 10.1038/cgt.2010.6pubmed: 20150931google scholar: lookup
                27. Villemejane J, Mir LM. Physical methods of nucleic acid transfer: general concepts and applications.. Br J Pharmacol 2009 May;157(2):207-19.